• N/A
    Market Cap
  • 3.98%
    1-Year Change
  • Shell Companies
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics have announced a definitive business combination agreement. Upon closing, the companies will form Ignite Proteomics Holdings, Inc. (PubCo), to be listed on the NYSE. The transaction values Ignite at a $150 million pro forma enterprise value and is expected to close in the second half of 2026. Ignite Proteomics specializes in pathway-level protein analytics for precision oncology.

06/11/2026, 6:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$10.43
$10.44
$10.43
1-Year Range
$10.04
$10.45
$10.43
Latest Close$10.43
Change
-$0.01 (-0.14%)
Volume219
Shares Outstanding18.0M
P/E (TTM)32.76
Diluted EPS (TTM)$0.32

Information as of 06/23/2026

Company Profile

COPLEY ACQUISITION CORP
https://www.copleyacquisition.com
N/A
Market Cap
$5.5M
Net Income
Sector: Financial Services
Industry: Shell Companies
One Exchange Square, Central, Hong Kong
852 2861 3335

Copley Acquisition Corp does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying companies in the technology or lifestyle sectors in the Asia Pacific and North American region. Copley Acquisition Corp was incorporated in 2024 and is based in Central, Hong Kong.

Key Executives

  • Menghan Zhang
  • Tok Li
  • Chibo Tang
  • Chun Kit Chu
  • Chi Yin Ng

Current Ownership Distribution

  • Other23.4M (98.60%)
  • Mutual Funds331,038 (1.40%)
  • Institutions0 (0.00%)
  • Insiders0 (0.00%)